All routine, specialized, and advanced staining procedures – including IHC and Biomarkers – are conducted onsite in our laboratory under CLIA.
The Clinical Laboratory Improvement Amendments (CLIA) of 1988 are the United States federal regulatory standards that apply to all clinical laboratory testing performed on humans in the United States, except clinical trials and basic research.
Histopath offers a High Quality Assurance Standard on all our diagnoses. Quality Assurance of Biomarkers are monitored by College of American Pathology.